HPV Vaccine Study for Rural Kids 8 to 12
Part of Cancer, Infections clinical trials.
This study aims to help prevent HPV-related cancers by increasing HPV vaccination rates in rural areas. It is for parents of 8- to 12-year-olds who have not yet completed the two-dose HPV vaccine series.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 8 and 12 years old.
- Your child must have visited the clinic in the past year or be willing to come in for the study.
- Your child cannot have already received both doses of the HPV vaccine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how HPV vaccines are given to girls in Ethiopia, aiming to improve access and uptake. It involves interviews and surveys with girls and their caregivers.
This study looks at how to better encourage teens and their parents to get the HPV vaccine, which protects against certain cancers. It aims to make vaccination easier and more acceptable for families.
This study tests a program designed to help primary care practices increase HPV vaccination rates among adolescents aged 9 to 12 who haven't yet been vaccinated. It aims to find out if providing practices with resources and support can lead to more kids getting the HPV vaccine.
This study helps make sure kids get the HPV vaccine during routine checkups. It is for children who have not yet had any dose of the HPV vaccine.
This study tests a program that helps adolescent girls and their caregivers learn about the HPV vaccine together. It aims to make it easier for families to decide whether to get the vaccine, which protects against certain cancers and other diseases.
This trial tests a program at school health centers to help teens get their HPV vaccine and learn about wellness. If you're due for the HPV shot, this could be a helpful way to get it in a familiar place.
Hear when a new Papillomavirus Vaccines trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.